191 related articles for article (PubMed ID: 28487462)
1. Association of endotoxaemia with serum free fatty acids in metabolically healthy and unhealthy abdominally obese individuals: a case-control study in northwest of Iran.
Saghafi-Asl M; Amiri P; Naghizadeh M; Ghavami SM; Karamzad N
BMJ Open; 2017 May; 7(5):e015910. PubMed ID: 28487462
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor signaling and serum levels of interferon β and lipopolysaccharide binding protein are related to abdominal obesity: a case-control study between metabolically healthy and metabolically unhealthy obese individuals.
Naghizadeh M; Baradaran B; Saghafi-Asl M; Amiri P; Shanehbandi D; Karamzad N; Mohamed-Khosroshahi L
Nutr Res; 2018 Jul; 55():11-20. PubMed ID: 29914624
[TBL] [Abstract][Full Text] [Related]
3. Association of proinflammatory genes expression with serum interleukin 1β and free fatty acids in metabolically healthy and unhealthy abdominally obese individuals: a case-control study.
Amiri P; Baradaran B; Saghafi-Asl M; Naghizadeh M; Shanehbandi D; Karamzad N; Vahed SZ
BMC Immunol; 2019 Jul; 20(1):23. PubMed ID: 31272370
[TBL] [Abstract][Full Text] [Related]
4. Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran Lipid and Glucose Study.
Eshtiaghi R; Keihani S; Hosseinpanah F; Barzin M; Azizi F
Int J Obes (Lond); 2015 Mar; 39(3):514-9. PubMed ID: 25287753
[TBL] [Abstract][Full Text] [Related]
5. Concentrations of Plasma Free Palmitoleic and Dihomo-Gamma Linoleic Fatty Acids Are Higher in Children with Abdominal Obesity.
Aristizabal JC; González-Zapata LI; Estrada-Restrepo A; Monsalve-Alvarez J; Restrepo-Mesa SL; Gaitán D
Nutrients; 2018 Jan; 10(1):. PubMed ID: 29301242
[TBL] [Abstract][Full Text] [Related]
6. Abdominal Obesity Phenotypes and Incidence of Thyroid Autoimmunity: A 9-Year Follow-up.
Amouzegar A; Kazemian E; Abdi H; Gharibzadeh S; Tohidi M; Azizi F
Endocr Res; 2020 Aug; 45(3):202-209. PubMed ID: 32266835
[TBL] [Abstract][Full Text] [Related]
7. All-cause mortality risk of metabolically healthy abdominal obese individuals: the EPIC-MORGEN study.
van der A DL; Nooyens AC; van Duijnhoven FJ; Verschuren MM; Boer JM
Obesity (Silver Spring); 2014 Feb; 22(2):557-64. PubMed ID: 23595997
[TBL] [Abstract][Full Text] [Related]
8. Abdominal obesity phenotypes and incident diabetes over 12 years of follow-up: The Tehran Lipid and glucose study.
Salehinia F; Abdi H; Hadaegh F; Serahati S; Valizadeh M; Azizi F; Hosseinpanah F
Diabetes Res Clin Pract; 2018 Oct; 144():17-24. PubMed ID: 30036611
[TBL] [Abstract][Full Text] [Related]
9. Association of dietary inflammatory index with metabolic profile in metabolically healthy and unhealthy obese people.
Abdurahman AA; Azadbakhat L; Rasouli M; Chamari M; Qorbani M; Dorosty AR
Nutr Diet; 2019 Apr; 76(2):192-198. PubMed ID: 30402959
[TBL] [Abstract][Full Text] [Related]
10. The association of dietary patterns with dietary inflammatory index, systemic inflammation, and insulin resistance, in apparently healthy individuals with obesity.
Saghafi-Asl M; Mirmajidi S; Asghari Jafarabadi M; Vahid F; Shivappa N; Hébert JR; Ebrahimzadeh Attari V
Sci Rep; 2021 Apr; 11(1):7515. PubMed ID: 33824355
[TBL] [Abstract][Full Text] [Related]
11. Abdominal obesity phenotypes and risk of kidney function decline: Tehran Lipid and Glucose Study.
Shahali A; Tasdighi E; Barzin M; Mahdavi M; Valizadeh M; Niroomand M; Azizi F; Hosseinpanah F
Obes Res Clin Pract; 2020; 14(2):168-175. PubMed ID: 32307280
[TBL] [Abstract][Full Text] [Related]
12. Risk of all-cause mortality in abdominal obesity phenotypes: Tehran Lipid and Glucose Study.
Doustmohamadian S; Serahati S; Barzin M; Keihani S; Azizi F; Hosseinpanah F
Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):241-248. PubMed ID: 28139376
[TBL] [Abstract][Full Text] [Related]
13. Circulating lipopolysaccharide-binding protein and carotid intima-media thickness in obstructive sleep apnea.
Trojova I; Kozarova M; Petrasova D; Malachovska Z; Paranicova I; Joppa P; Tkacova R
Physiol Res; 2018 Mar; 67(1):69-78. PubMed ID: 29137477
[TBL] [Abstract][Full Text] [Related]
14. Abdominal obesity phenotypes and risk of cardiovascular disease in a decade of follow-up: the Tehran Lipid and Glucose Study.
Keihani S; Hosseinpanah F; Barzin M; Serahati S; Doustmohamadian S; Azizi F
Atherosclerosis; 2015 Feb; 238(2):256-63. PubMed ID: 25540856
[TBL] [Abstract][Full Text] [Related]
15. The change in one-hour postload plasma glucose levels, and an analysis of its related factors in abdominally obese Han Chinese men with normal glucose tolerance.
Qin CM; Wang R; Yin FZ; Liu B; Ma CM; Lu Q
J Diabetes Complications; 2012; 26(6):536-9. PubMed ID: 22739800
[TBL] [Abstract][Full Text] [Related]
16. Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea.
Barceló A; Piérola J; de la Peña M; Esquinas C; Fuster A; Sanchez-de-la-Torre M; Carrera M; Alonso-Fernandez A; Ladaria A; Bosch M; Barbé F
Eur Respir J; 2011 Jun; 37(6):1418-23. PubMed ID: 21177837
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Potential of Diet: Association With Chemerin, Omentin, Lipopolysaccharide-Binding Protein, and Insulin Resistance in the Apparently Healthy Obese.
Mirmajidi S; Izadi A; Saghafi-Asl M; Vahid F; Karamzad N; Amiri P; Shivappa N; Hébert JR
J Am Coll Nutr; 2019; 38(4):302-310. PubMed ID: 30252613
[TBL] [Abstract][Full Text] [Related]
18. Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals.
Ni Y; Zhao L; Yu H; Ma X; Bao Y; Rajani C; Loo LW; Shvetsov YB; Yu H; Chen T; Zhang Y; Wang C; Hu C; Su M; Xie G; Zhao A; Jia W; Jia W
EBioMedicine; 2015 Oct; 2(10):1513-22. PubMed ID: 26629547
[TBL] [Abstract][Full Text] [Related]
19. Markers of systemic exposures to products of intestinal bacteria in a dietary intervention study.
Umoh FI; Kato I; Ren J; Wachowiak PL; Ruffin MT; Turgeon DK; Sen A; Brenner DE; Djuric Z
Eur J Nutr; 2016 Mar; 55(2):793-798. PubMed ID: 25903259
[TBL] [Abstract][Full Text] [Related]
20. Postprandial Endotoxemia Linked With Chylomicrons and Lipopolysaccharides Handling in Obese Versus Lean Men: A Lipid Dose-Effect Trial.
Vors C; Pineau G; Drai J; Meugnier E; Pesenti S; Laville M; Laugerette F; Malpuech-Brugère C; Vidal H; Michalski MC
J Clin Endocrinol Metab; 2015 Sep; 100(9):3427-35. PubMed ID: 26151336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
